Clinical researchers around the world are in the race to find an effective vaccine and treatments for the novel coronavirus that has taken the world by surprise this year. With the help of AI-technology and access to breakthrough antibody testing, Cedar Health Research, stands ready to enroll and execute faster for upcoming COVID-19 clinical trials.
Backed by Experience
Backed by over 50 years of combined clinical trial investigator experience, including numerous vaccine trials, Cedar Health Research is ready to execute COVID-19 trials across its network of sites. With the advanced recruitment capabilities of Aspen Insights, Cedar Health Research can enroll vaccine trials at a rate that simply cannot be matched. The leadership of Cedar Health Research has experience in numerous vaccine trial types, to include:
- HPV
- Hepatitis
- Influenza
- Staphylococcus
- Sexually Transmitted Infection / Disease
Integrated Lab Testing
With the power of Aspen Insight’s technology, Cedar Health Research can rapidly locate trial patients in a specific area with a high probability of being eligible candidates for a given trial; in this case, COVID-19. Arbor Diagnostics, the lab that Cedar Health Research and Aspen Insights partner with for clinical trial testing and analytics, has acquired the capability to perform high level, discrete COVID PCR and Roche total antibody testing.
By generating eligibility probability through Aspen Insight’s AI-technology and accessing crucial testing analytics through Arbor Diagnostics, we can truly accelerate research efforts.
Feasibility and Timelines
Cedar Health Research, with the power of Aspen Insight’s technology, rapidly locates patients in a specific area that have a high probability of being eligible candidates for a given trial. Patient eligibility probability is generated using patient-specific clinical history increasing the likelihood of accurate identification, accelerated subject targeting, and ultimately, faster trial enrollment.
Patient Recruitment Sources
For the Cedar Health Network of sites, locating qualified patients for a study is faster and more efficient than ever before, with a patient population of over 300,000 unique lives being referred from over 30 physician EMR patient databases. These established relationships improve the clinical trial model by leveraging direct partnerships with community-based private practices.
The protocol inclusion/exclusion criteria for each new study is plugged into Aspen Insight’s state-of-the-art technology. As a result, highly probably candidates are identified, and site doctors and staff can quickly contact and schedule volunteers for screening visits. Volunteers can present and enroll at a nearby Cedar Health Research site, making clinical trial awareness and participation quick and convenient for volunteers.
 |
 |
| Private Practice Partnership | Patient Access |
| Physician engaged recruitment | Immediately recruit-able population |
| Patient outcomes monitoring | Sharing of EHR data |
| Diagnostic lab network with access through LIS (Laboratory Information Systems) integration |
Get in Touch
At Cedar Health Research, it is our mission to transform the clinical research domain through the effective adoption of innovative technologies. Cedar Health Research, with the power of Aspen Insights technology and Arbor Diagnostics capabilities, strives to give back to the research community by providing accurate data and faster timelines in response to the COVID-19 pandemic.
If you are a Sponsor and CRO, and would like to leverage Cedar Health Research as an end-to-end site-network solution for your COVID-19 study, please contact us today.
To get in touch, contact us at (214) 253-8170 or CLICK HERE to fill out a contact form.
